Rationally Engineered

Not all Cyclodextrins are created equally

Captisol® is a patent protected, uniquely modified cyclodextrin, whose chemical structure was rationally designed to enable the creation of new products by significantly improving solubility, stability, bioavailability and dosing of active pharmaceutical ingredients (APIs).

Request SampleOrder Now

Recent Events

Captisol at AAPS 2016 Booth # 304

Social

November 7, 2016

Aldeyra to present ADX-102 Ph2 data at 2016 American College of Allergy, Asthma and Immunology Annual Meeting https://t.co/3F5hsEfKoo

Your Partner in Solubility
The Clear Advantage

Partners

Merck
Baxter
Pfizer
Bristol-Myers Squibb
Amgen
Melinta
Lundbeck
Lilly
Celgene
Spectrum Pharmaceuticals